131 related articles for article (PubMed ID: 1642407)
1. The evaluation of putative tumor markers for malignant melanoma.
Reintgen DS; Cruse CW; Wells KE; Saba HI; Fabri PJ
Ann Plast Surg; 1992 Jan; 28(1):55-9. PubMed ID: 1642407
[TBL] [Abstract][Full Text] [Related]
2. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of new putative tumor markers for melanoma.
Miliotes G; Lyman GH; Cruse CW; Puleo C; Albertini PA; Rapaport D; Glass F; Fenske N; Soriano T; Cuny C; Van Voorhis N; Reintgen D
Ann Surg Oncol; 1996 Nov; 3(6):558-63. PubMed ID: 8915488
[TBL] [Abstract][Full Text] [Related]
4. Neuron-specific enolase--a serum marker for malignant melanoma.
Lorenz J; Dippold W
J Natl Cancer Inst; 1989 Nov; 81(22):1754-5. PubMed ID: 2810389
[No Abstract] [Full Text] [Related]
5. Lipid associated sialic acid in plasma in patients with advanced carcinoma of the ovaries.
Vardi JR; Tadros GH; Malhotra C; Charney T; Shebes M; Foemmel R
Surg Gynecol Obstet; 1989 Apr; 168(4):296-301. PubMed ID: 2928903
[TBL] [Abstract][Full Text] [Related]
6. Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
Musset M; Mathé G; Reizenstein P
Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):17-20. PubMed ID: 2663215
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer and family history: levels of lipid-associated sialic acid in plasma and absent family history of breast cancer in women who have breast tumors.
Brower ST; Tartter P; Weiss S; Luderer AA; Lehrer S
Mt Sinai J Med; 1995 Nov; 62(6):419-21. PubMed ID: 8692154
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum sialic acid fractions as markers for malignant melanoma.
Vedralová E; Borovanský J
Cancer Lett; 1994 Apr; 78(1-3):171-5. PubMed ID: 8180959
[TBL] [Abstract][Full Text] [Related]
9. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Andersen JW
Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
[TBL] [Abstract][Full Text] [Related]
10. Serum sialic acid elevations in malignant melanoma patients.
Silver HK; Rangel DM; Morton DL
Cancer; 1978 Apr; 41(4):1497-9. PubMed ID: 639006
[TBL] [Abstract][Full Text] [Related]
11. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
[TBL] [Abstract][Full Text] [Related]
12. [Serum sialic acid bound to lipoproteins. Its contribution to the diagnosis and follow-up of melanoma].
Sánchez Conejo-Mir J; Sotillo Gago I; Camacho F; Iglesias Huertas R
Med Cutan Ibero Lat Am; 1990; 18(4):219-23. PubMed ID: 2077306
[TBL] [Abstract][Full Text] [Related]
13. Individual and combined usefulness of lipid associated sialic acid, mucoid proteins and hexoses as tumor markers in breast carcinoma.
Patel PS; Baxi BR; Adhvaryu SG; Balar DB
Cancer Lett; 1990 Jun; 51(3):203-8. PubMed ID: 2161706
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum CA-125 and lipid-associated sialic acid (LASA-P) in monitoring patients with invasive ovarian adenocarcinoma.
Patsner B; Mann WJ; Vissicchio M; Loesch M
Gynecol Oncol; 1988 May; 30(1):98-103. PubMed ID: 2452774
[TBL] [Abstract][Full Text] [Related]
15. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
Tseng PC; Sprance HE; Carcangiu ML; Chambers JT; Schwartz PE
Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
[TBL] [Abstract][Full Text] [Related]
16. Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement.
Plucinsky MC; Riley WM; Prorok JJ; Alhadeff JA
Cancer; 1986 Dec; 58(12):2680-5. PubMed ID: 3779617
[TBL] [Abstract][Full Text] [Related]
17. Improved procedure for determination of serum lipid-associated sialic acid: application for early diagnosis of colorectal cancer.
Tautu C; Verazin G; Prorok JJ; Alhadeff JA
J Natl Cancer Inst; 1988 Oct; 80(16):1333-7. PubMed ID: 3172258
[TBL] [Abstract][Full Text] [Related]
18. [Laboratory markers of melanoma progression].
Bánfalvi T; Edesné MB; Gergye M; Udvarhelyi N; Orosz Z; Gilde K; Kremmer T; Ottó S; Tímár J
Magy Onkol; 2003; 47(1):89-104. PubMed ID: 12704461
[TBL] [Abstract][Full Text] [Related]
19. Serum sialic acid concentrations in malignant melanoma.
Ryan AH; Fennelly JJ
Eur J Cancer Clin Oncol; 1981 Jul; 17(7):843-4. PubMed ID: 7199476
[No Abstract] [Full Text] [Related]
20. Clinical significance of serum S100 in metastatic malignant melanoma.
Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
Eur J Cancer; 1995 Jun; 31A(6):924-8. PubMed ID: 7646923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]